Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Roger G. Harrison:

Predicting the solubility of recombinant proteins in Escherichia coli. Harrison RG et al. Methods Mol Biol. (2015)

Annexin-directed β-glucuronidase for the targeted treatment of solid tumors. Guillen KP et al. Protein Eng Des Sel. (2017)

Divalent copper complexes as influenza A M2 inhibitors. Gordon NA et al. Antiviral Res. (2017)

Search results

Items: 1 to 20 of 47

1.

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Sep;14(9):902. doi: 10.1038/s41565-019-0538-3.

PMID:
31358944
2.

Publisher Correction: On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufès C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, Neves JD, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Aug;14(8):811. doi: 10.1038/s41565-019-0523-x.

PMID:
31289407
3.

On the issue of transparency and reproducibility in nanomedicine.

Leong HS, Butler KS, Brinker CJ, Azzawi M, Conlan S, Dufés C, Owen A, Rannard S, Scott C, Chen C, Dobrovolskaia MA, Kozlov SV, Prina-Mello A, Schmid R, Wick P, Caputo F, Boisseau P, Crist RM, McNeil SE, Fadeel B, Tran L, Hansen SF, Hartmann NB, Clausen LPW, Skjolding LM, Baun A, Ågerstrand M, Gu Z, Lamprou DA, Hoskins C, Huang L, Song W, Cao H, Liu X, Jandt KD, Jiang W, Kim BYS, Wheeler KE, Chetwynd AJ, Lynch I, Moghimi SM, Nel A, Xia T, Weiss PS, Sarmento B, das Neves J, Santos HA, Santos L, Mitragotri S, Little S, Peer D, Amiji MM, Alonso MJ, Petri-Fink A, Balog S, Lee A, Drasler B, Rothen-Rutishauser B, Wilhelm S, Acar H, Harrison RG, Mao C, Mukherjee P, Ramesh R, McNally LR, Busatto S, Wolfram J, Bergese P, Ferrari M, Fang RH, Zhang L, Zheng J, Peng C, Du B, Yu M, Charron DM, Zheng G, Pastore C.

Nat Nanotechnol. 2019 Jul;14(7):629-635. doi: 10.1038/s41565-019-0496-9. No abstract available. Erratum in: Nat Nanotechnol. 2019 Aug;14(8):811. Nat Nanotechnol. 2019 Sep;14(9):902.

PMID:
31270452
4.

A visible chemosensor based on carbohydrazide for Fe(ii), Co(ii) and Cu(ii) in aqueous solution.

Yang M, Chae JB, Kim C, Harrison RG.

Photochem Photobiol Sci. 2019 May 15;18(5):1249-1258. doi: 10.1039/c8pp00545a.

PMID:
30865746
5.

Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer.

Virani NA, Thavathiru E, McKernan P, Moore K, Benbrook DM, Harrison RG.

Cancer Lett. 2018 Jul 1;425:174-182. doi: 10.1016/j.canlet.2018.03.027. Epub 2018 Mar 21.

PMID:
29574275
6.

The Nicotine Content of a Sample of E-cigarette Liquid Manufactured in the United States.

Raymond BH, Collette-Merrill K, Harrison RG, Jarvis S, Rasmussen RJ.

J Addict Med. 2018 Mar/Apr;12(2):127-131. doi: 10.1097/ADM.0000000000000376.

PMID:
29280749
7.

Phosphatidylserine targeted single-walled carbon nanotubes for photothermal ablation of bladder cancer.

Virani NA, Davis C, McKernan P, Hauser P, Hurst RE, Slaton J, Silvy RP, Resasco DE, Harrison RG.

Nanotechnology. 2018 Jan 19;29(3):035101. doi: 10.1088/1361-6528/aa9c0c.

PMID:
29160225
8.

Divalent copper complexes as influenza A M2 inhibitors.

Gordon NA, McGuire KL, Wallentine SK, Mohl GA, Lynch JD, Harrison RG, Busath DD.

Antiviral Res. 2017 Nov;147:100-106. doi: 10.1016/j.antiviral.2017.10.009. Epub 2017 Oct 12.

PMID:
29032206
9.

Antitumor Synergism and Enhanced Survival with a Tumor Vasculature-Targeted Enzyme Prodrug System, Rapamycin, and Cyclophosphamide.

Krais JJ, Virani N, McKernan PH, Nguyen Q, Fung KM, Sikavitsas VI, Kurkjian C, Harrison RG.

Mol Cancer Ther. 2017 Sep;16(9):1855-1865. doi: 10.1158/1535-7163.MCT-16-0263. Epub 2017 May 18.

10.

A zinc fluorescent sensor used to detect mercury (II) and hydrosulfide.

Jung JM, Lee JJ, Nam E, Lim MH, Kim C, Harrison RG.

Spectrochim Acta A Mol Biomol Spectrosc. 2017 May 5;178:203-211. doi: 10.1016/j.saa.2017.02.006. Epub 2017 Feb 7.

PMID:
28189093
11.

Annexin-directed β-glucuronidase for the targeted treatment of solid tumors.

Guillen KP, Ruben EA, Virani N, Harrison RG.

Protein Eng Des Sel. 2017 Feb;30(2):85-94. doi: 10.1093/protein/gzw063. Epub 2016 Dec 15.

12.

A new approach for trace analysis of guanidine compounds in surface water with resorcinarene-based ion chromatography columns.

Panahi T, Weaver DJ, Lamb JD, Harrison RG.

Analyst. 2016 Feb 7;141(3):939-46. doi: 10.1039/c5an01076d.

PMID:
26649362
13.

Optical and Magnetic Properties of ZnO Nanoparticles Doped with Co, Ni and Mn and Synthesized at Low Temperature.

Hancock JM, Rankin WM, Hammad TM, Salem JS, Chesnel K, Harrison RG.

J Nanosci Nanotechnol. 2015 May;15(5):3809-15.

PMID:
26505009
14.

Annexin V-Directed Enzyme Prodrug Therapy Plus Docetaxel for the Targeted Treatment of Pancreatic Cancer.

Guillen KP, Restuccia A, Kurkjian C, Harrison RG.

Pancreas. 2015 Aug;44(6):945-52. doi: 10.1097/MPA.0000000000000343.

PMID:
25899647
15.

Separation of uremic toxins from urine with resorcinarene-based ion chromatography columns.

Panahi T, Weaver DJ, Lamb JD, Harrison RG.

J Chromatogr A. 2015 Jan 9;1376:105-11. doi: 10.1016/j.chroma.2014.12.026. Epub 2014 Dec 12.

PMID:
25537175
16.

Predicting the solubility of recombinant proteins in Escherichia coli.

Harrison RG, Bagajewicz MJ.

Methods Mol Biol. 2015;1258:403-8. doi: 10.1007/978-1-4939-2205-5_23. Review.

PMID:
25447878
17.
18.

Purine nucleoside phosphorylase targeted by annexin v to breast cancer vasculature for enzyme prodrug therapy.

Krais JJ, De Crescenzo O, Harrison RG.

PLoS One. 2013 Oct 3;8(10):e76403. doi: 10.1371/journal.pone.0076403. eCollection 2013.

19.

Antitumor activity of an enzyme prodrug therapy targeted to the breast tumor vasculature.

Van Rite BD, Krais JJ, Cherry M, Sikavitsas VI, Kurkjian C, Harrison RG.

Cancer Invest. 2013 Oct;31(8):505-10. doi: 10.3109/07357907.2013.840383.

PMID:
24083814
20.

A single molecule that acts as a fluorescence sensor for zinc and cadmium and a colorimetric sensor for cobalt.

Song EJ, Kang J, You GR, Park GJ, Kim Y, Kim SJ, Kim C, Harrison RG.

Dalton Trans. 2013 Nov 21;42(43):15514-20. doi: 10.1039/c3dt51635k.

PMID:
24029919

Supplemental Content

Loading ...
Support Center